Chemicals

2-Fluoroethanamine hydrochloride Cas:460-08-2

We are 2-Fluoroethanamine hydrochloride CAS:460-08-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms：

Ethanamine, 2-fluoro-, hydrochloride

2-fluoroethanamine,hydrochloride

Molecular Formula: C2H7ClFN

Molecular weight：99.53510

Density: 0.892g/cm3

Boiling point: 52.1ºC at 760 mmHg

Melting point: 99-103ºC(lit.)

Flash point: 20.7ºC

Refractive index: 1.345

Vapor pressure: 269mmHg at 25°C

Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.

Market News: In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks.[6-Chloro-3-(4-chloro-phenyl)-1-oxo-1H-inden-2-yl]-acetic acid manufacturer.McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 6-(4-acetylamino-phenyl)-3-methylsulfanyl-2(4)H-[1,2,4]triazin-5-one supplier With its offering of API development, GMP manufacturing, solid state chemistry and analytical expertise, Onyx continues to experience strong growth driven by demand from biotech and pharmaceutical companies for its integrated CMC capabilities. 5-(3-bromophenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide producer

Product Name
N-[4-[4-(naphthalen-1-ylamino)phenyl]phenyl]naphthalen-1-amine	View Details
L-Alaninol	View Details
Acetyl Hexapeptide-37	View Details